Estriol (E3) is a naturally occurring estrogen and becomes the dominant form during pregnancy, when it is produced in large amounts by the placenta. In women who are not pregnant, estriol levels are very low because it is formed mainly in the liver as a byproduct of estrone and estradiol metabolism.
Although both women and men make estriol, men may produce only small amounts.
Estriol is considered the weakest of the three primary estrogens and binds less strongly to estrogen receptors, giving it short‑acting effects. This weaker activity may reduce some of the risks linked to stronger estrogens while still supporting certain estrogen‑related processes.
Interest in estriol has grown because of its unique biological profile and its potential roles in areas such as immune regulation and menopausal symptom support. Estriol is available as a compounded bioidentical hormone and may be prepared in several forms, including but not limited to estriol cream, estriol hormone cream, estriol vaginal cream, and estriol tablets.
Estriol is a weaker, short‑acting estrogen that may support postmenopausal women by helping maintain urogenital tissue health and providing relief from symptoms related to low estrogen levels. Its unique profile and lower receptor potency have led to growing interest in its potential to offer benefits with fewer effects typically associated with stronger estrogens.
Estriol’s weaker estrogenic activity has been associated with supporting bone maintenance that may limit bone resorption. Its use has been explored in those with age‑related bone‑health concerns, where maintaining bone density is important for long‑term skeletal strength.
Estriol has emerging immunomodulatory properties that may help regulate immune activity in certain autoimmune or inflammatory conditions. Research suggests it may influence pro‑inflammatory cytokines and support immune balance in disorders such as multiple sclerosis and rheumatoid arthritis.
Bioidentical hormones, predominantly isolated from plant materials, have the exact chemical and molecular structure as hormones made in the human body. Bioidentical steroid hormones like estriol are designed to bind to the same receptors and undergo similar enzymatic breakdown. Dose and delivery route are essential to activity, which is why compounded bioidentical hormone replacement therapy (BHRT) offers distinctive options that maximize therapeutic use.
Estriol cream may be well‑tolerated with its weaker estrogenic activity contributing to a lower risk profile compared to stronger estrogens. Professional guidance is recommended when considering its use.
Estriol is considered the weakest of the major estrogens, but like other unopposed estrogens, it may contribute to side effects such as bloating or weight gain. These effects may improve when hormone balance, dosing, or formulation—such as the form of estriol being used—is adjusted with guidance from a healthcare professional.
January 15, 2026
A woman’s value extends beyond her appearance. Self-worth isn’t skin deep – she contains multitudes. And yet, how she presents herself to the world is an integral part of her identity. Body image perception is […]
June 2, 2023
Your doctor prescribed a compounded hormone cream. Now what? If you’re like most patients, you probably have some questions about […]
April 12, 2022
Since the publication of the Women’s Health Initiative (WHI) study results were reported in 2002, many doctors and patients alike […]
February 8, 2022
Life during menopause can be tough. Between the hot flashes, mood swings, and sleepless nights, hormones can be your best […]
April 20, 2020
Is your patient experiencing the following symptoms? If you answered “yes” to any of the conditions above, this may make […]
